Tissue Repair
How Regenerative Cells Accelerate Tissue Healing
A landmark study explored the paracrine signaling mechanisms by which regenerative cells communicate with surrounding tissue. Findings confirmed that secreted growth factors and cytokines play a central role in activating the body's own repair pathways — pointing to significant clinical potential beyond direct cell engraftment.
Baranaki PR & McDevitt TC. Regenerative Medicine. 2010 Jan.
Read Study →
Rheumatoid Arthritis
Clinical Outcomes of Umbilical Cord Biologics in Autoimmune Joint Disease
This clinical investigation enrolled patients with active, treatment-resistant rheumatoid arthritis and evaluated outcomes following umbilical cord cell therapy. Results showed statistically significant functional improvement across validated disease activity measures, suggesting a meaningful role for allograft biologics in managing chronic autoimmune inflammation.
Wang et al. Stem Cells Development. 2013 Dec.
Read Study →
Osteoarthritis
Direct Joint Injection as a Non-Surgical Path to Cartilage Restoration
A proof-of-concept trial evaluated the safety and clinical benefit of direct intra-articular mesenchymal cell injection in patients with knee osteoarthritis. The study demonstrated cartilage volume changes and functional improvements, raising the prospect of a minimally invasive alternative to surgical intervention for degenerative joint conditions.
Jo CH et al. Stem Cells. 2014 May.
Read Study →
Immunomodulation
Umbilical Cord Cells Demonstrate Safe Immune-Tolerant Profile
A comparative in vitro analysis examined the immunological characteristics of human umbilical cord perivascular cells against bone marrow-derived counterparts. The data confirmed that cord-derived cells exhibit a highly favorable immune tolerance profile — making them well-suited for allogeneic applications without risk of immune rejection in properly screened patients.
Ennis J et al. Cytotherapy. 2008.
Read Study →
Heart Disease
Regenerative Cell Delivery Strategies in Cardiac Patients
The POSEIDON randomized controlled trial compared two delivery strategies for mesenchymal cell therapy in patients with ischemic cardiomyopathy. Both allogeneic and autologous approaches produced measurable reductions in infarct volume and improvements in cardiac function, underscoring the promise of regenerative biologics in heart failure management.
Hare JM et al. JAMA. 2012 Dec.
Read Study →
Diabetes
Regenerative Biologics & Pancreatic Function Restoration
Multiple studies have explored the use of mesenchymal cells to address the underlying immune dysregulation driving Type 1 diabetes. Research demonstrated that these cells can both generate insulin-producing cell precursors and induce regulatory T-cell populations that suppress autoimmune attack on the pancreas — a two-pronged therapeutic mechanism with strong translational potential.
Karnieli O et al. Stem Cells. 2007 Nov.
Read Study →
Lupus
Multi-Center Trial of Regenerative Therapy in Refractory Lupus
A multi-institutional clinical study enrolled patients with severe, treatment-refractory systemic lupus erythematosus and assessed outcomes following umbilical cord mesenchymal cell transplantation. Significant disease activity reductions were observed at follow-up, with a favorable safety profile — positioning regenerative therapy as a viable option where conventional immunosuppression has failed.
Wang D et al. Arthritis Research & Therapy. 2014 Mar.
Read Study →
Parkinson's Disease
Sustained Neurological Benefit Following Regenerative Cell Infusion
This open-label pilot study tracked neurological outcomes in Parkinson's patients over a multi-year period following mesenchymal cell transplantation. Participants demonstrated sustained improvement in motor function scores and quality-of-life measures, providing early clinical evidence for the neuroprotective and neuroregenerative potential of allograft biologics.
Venkataramana NK et al. Translational Research. 2010 Feb.
Read Study →
Organ Transplant
Pre-Transplant Biologics Reduce Graft Failure Risk in Kidney Recipients
Researchers evaluated the impact of pre-transplant mesenchymal stromal cell infusion on outcomes in kidney transplant recipients. Compared to controls, treated patients showed reduced rates of acute graft dysfunction, lower rejection-related immune activation, and improved long-term graft survival — highlighting a compelling preventative application for regenerative medicine in solid organ transplantation.
Perico N et al. Transplant International. 2013 Sep.
Read Study →
Infectious Disease
Mesenchymal Cells as Antimicrobial Agents in Resistant Infections
An emerging body of research has characterized the direct antimicrobial capabilities of mesenchymal cells — independent of their immune-modulating functions. Studies show these cells secrete peptides and proteins that inhibit bacterial growth and enhance macrophage clearance, with particular relevance to conditions like cystic fibrosis where conventional antibiotic therapy faces significant limitations.
Sutton MT et al. Stem Cells International. 2016.
Read Study →
